TGM2 and hydrops fetalis: Further, we propose new potential biomarkers of hypertrophy and/or HF (annexin A2 and A1) and, most importantly, suggest two highly potential therapeutic targets for the treatment of HF - monoamine oxidase A and transglutaminase 2.